Clinical trial
Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained…
NCT00207363 · Brooke Army Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00207363 |
|---|---|
| Title | Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC |
| Official title | Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C |
| Lead sponsor | Brooke Army Medical Center, U.S. Fed |
| Collaborators | T.R.U.E. Research Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Ribavirin, Peg interferon alfa 2b, induction therapy |
| Enrollment | 610 |
| Start date | Feb 1, 2002 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: